Lineage, Inc. Common Stock (LINE)vsRayonier Inc (RYN)
LINE
Lineage, Inc. Common Stock
$35.99
-1.64%
REAL ESTATE · Cap: $8.93B
RYN
Rayonier Inc
$21.22
-1.16%
REAL ESTATE · Cap: $6.45B
Smart Verdict
WallStSmart Research — data-driven comparison
Lineage, Inc. Common Stock generates 1005% more annual revenue ($5.36B vs $484.49M). RYN leads profitability with a 97.9% profit margin vs -1.9%. RYN earns a higher WallStSmart Score of 42/100 (D).
LINE
Hold36
out of 100
Grade: F
RYN
Hold42
out of 100
Grade: D
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+75.9%
Fair Value
$161.49
Current Price
$35.99
$125.50 discount
Intrinsic value data unavailable for RYN.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Keeps 98 of every $100 in revenue as profit
Reasonable price relative to book value
Strong operational efficiency at 28.3%
Areas to Watch
0.0% earnings growth
ROE of -1.2% — below average capital efficiency
Revenue declined 0.2%
Distress zone — elevated risk
ROE of 3.6% — below average capital efficiency
Weak financial health signals
Expensive relative to growth rate
Premium valuation, high expectations priced in
Comparative Analysis Report
WallStSmart ResearchBull Case : LINE
The strongest argument for LINE centers on Price/Book.
Bull Case : RYN
The strongest argument for RYN centers on Profit Margin, Price/Book, Operating Margin. Profitability is solid with margins at 97.9% and operating margin at 28.3%.
Bear Case : LINE
The primary concerns for LINE are EPS Growth, Return on Equity, Revenue Growth.
Bear Case : RYN
The primary concerns for RYN are Return on Equity, Piotroski F-Score, PEG Ratio. A P/E of 45.1x leaves little room for execution misses.
Key Dynamics to Monitor
LINE profiles as a turnaround stock while RYN is a declining play — different risk/reward profiles.
LINE is growing revenue faster at -0.2% — sustainability is the question.
LINE generates stronger free cash flow (78M), providing more financial flexibility.
Monitor REIT - INDUSTRIAL industry trends, competitive dynamics, and regulatory changes.
Bottom Line
RYN scores higher overall (42/100 vs 36/100), backed by strong 97.9% margins. LINE offers better value entry with a 75.9% margin of safety. Both earn "Hold" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Lineage, Inc. Common Stock
REAL ESTATE · REIT - INDUSTRIAL · USA
Lineage, Inc. (Ticker: LINE) is a pioneering biotechnology firm focused on regenerative medicine, specifically developing cutting-edge cell therapy solutions for treating debilitating conditions, including ocular diseases, spinal cord injuries, and various cancers. With its proprietary technologies and robust network of strategic collaborations, Lineage is poised to transform patient care through innovative therapeutic interventions. The company's commitment to advancing its diverse product pipeline and expediting clinical research positions it as an attractive investment opportunity for institutional investors seeking to engage in the forefront of healthcare advancements.
Visit Website →Rayonier Inc
REAL ESTATE · REIT - SPECIALTY · USA
Rayonier is a leading timber real estate investment trust with assets located in some of the most productive softwood producing regions in the United States and New Zealand.
Compare with Other REIT - INDUSTRIAL Stocks
Want to dig deeper into these stocks?